| pubmed-article:2975953 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2975953 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:2975953 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:2975953 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:2975953 | lifeskim:mentions | umls-concept:C0042149 | lld:lifeskim |
| pubmed-article:2975953 | lifeskim:mentions | umls-concept:C0242275 | lld:lifeskim |
| pubmed-article:2975953 | lifeskim:mentions | umls-concept:C0023267 | lld:lifeskim |
| pubmed-article:2975953 | lifeskim:mentions | umls-concept:C0023610 | lld:lifeskim |
| pubmed-article:2975953 | lifeskim:mentions | umls-concept:C0243192 | lld:lifeskim |
| pubmed-article:2975953 | lifeskim:mentions | umls-concept:C1167622 | lld:lifeskim |
| pubmed-article:2975953 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:2975953 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:2975953 | pubmed:dateCreated | 1989-4-4 | lld:pubmed |
| pubmed-article:2975953 | pubmed:abstractText | The binding of epidermal growth factor (EGF) to human myometrium and leiomyomata was assessed in a group of women rendered hypo-oestrogenic with the LHRH agonist Zoladex (ICI 118630). The results were compared with those obtained with tissues from women with normal cycles. In normal women, the specific binding of radiolabelled [125I] EGF to both myometrial and fibroid homogenates did not vary during the menstrual cycle, but the specific binding of [125I] EGF to fibroid in women treated with LHRH agonist was significantly less than in the untreated group. Since the hypo-oestrogenic state induced by the agonist is associated with a decrease in fibroid size, the results suggest that the effect of oestrogen on fibroid tissue may partly be mediated by EGF. | lld:pubmed |
| pubmed-article:2975953 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2975953 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2975953 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:2975953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2975953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2975953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2975953 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2975953 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2975953 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:2975953 | pubmed:issn | 0306-5456 | lld:pubmed |
| pubmed-article:2975953 | pubmed:author | pubmed-author:BairdD TDT | lld:pubmed |
| pubmed-article:2975953 | pubmed:author | pubmed-author:WestC PCP | lld:pubmed |
| pubmed-article:2975953 | pubmed:author | pubmed-author:LumsdenM AMA | lld:pubmed |
| pubmed-article:2975953 | pubmed:author | pubmed-author:BramleyTT | lld:pubmed |
| pubmed-article:2975953 | pubmed:author | pubmed-author:RumgayLL | lld:pubmed |
| pubmed-article:2975953 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2975953 | pubmed:volume | 95 | lld:pubmed |
| pubmed-article:2975953 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2975953 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2975953 | pubmed:pagination | 1299-304 | lld:pubmed |
| pubmed-article:2975953 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:meshHeading | pubmed-meshheading:2975953-... | lld:pubmed |
| pubmed-article:2975953 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2975953 | pubmed:articleTitle | The binding of epidermal growth factor to the human uterus and leiomyomata in women rendered hypo-oestrogenic by continuous administration of an LHRH agonist. | lld:pubmed |
| pubmed-article:2975953 | pubmed:affiliation | Department of Obstetrics and Gynaecology, University of Edinburgh. | lld:pubmed |
| pubmed-article:2975953 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2975953 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2975953 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2975953 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2975953 | lld:pubmed |
